Pulmonary Hypertension


Pulmonary Hypertension characterized as a pneumonic blood vessel weight more noteworthy than 25 mm Hg very still or more prominent than 30 mm Hg amid exercise is frequently portrayed by a dynamic and continued increment in aspiratory vascular opposition that in the long run may prompt right ventricular disappointment. It very well may be a perilous condition if untreated. Treatment for Pulmonary Hypertension is focused at the basic reason and its consequences for the cardiovascular framework.


  • Pulmonary Arterial Hypertension (PAH)
  • Pulmonary Hypertension Due to Left Heart Disease
  • Pulmonary Hypertension Due to Lung Disease
  • Pulmonary Hypertension Due to Chronic Blood Clots in the Lungs

Related Conference of Pulmonary Hypertension

October 23-24, 2025

13th Annual Congress on Pulmonary and Critical Care

Paris, France
April 27-28, 2026

2nd World Congress on Pathology and Laboratory Medicine

Paris, Aland Islands

Pulmonary Hypertension Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in